Linked Life Data

19911521

Source:http://linkedlifedata.com/resource/pubmed/id/19911521

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2009-11-16
pubmed:abstractText
Essential thrombocythemia is a chronic myeloproliferative disease with possible thrombotic and hemorrhagic complications due to an abnormal increase in platelets. It is diagnosed by platelet count and the presence of increased numbers of megakaryocytes in the bone marrow. Most patients remain asymptomatic, although thrombotic events can occur in most systems of the body. A number of treatment medications are available, including hydroxyurea, anagrelide, interferon alpha, and sodium salicylate. Aeromedical disposition of aircrew engaged in civil and military aviation would depend upon the nature of operations, tolerance to the medications prescribed, and the occurrence of complications. For spaceflight, disqualification would be most prudent.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0095-6562
pubmed:author
pubmed:issnType
Print
pubmed:volume
80
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
968-70
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Essential thrombocythemia: aeromedical considerations.
pubmed:affiliation
Aerospace Medical Association, Alexandria, VA, USA. rrayman@asma.org
pubmed:publicationType
Journal Article, Review